Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 42.183
Filtrar
1.
Geneva; World Health Organization; 2022-06-01.
em Inglês | WHO IRIS | ID: who-354776
2.
BMC Infect Dis ; 22(1): 558, 2022 Jun 19.
Artigo em Inglês | MEDLINE | ID: mdl-35718768

RESUMO

BACKGROUND: A global pandemic has been declared for coronavirus disease 2019 (COVID-19), which has serious impacts on human health and healthcare systems in the affected areas, including Vietnam. None of the previous studies have a framework to provide summary statistics of the virus variants and assess the severity associated with virus proteins and host cells in COVID-19 patients in Vietnam. METHOD: In this paper, we comprehensively investigated SARS-CoV-2 variants and immune responses in COVID-19 patients. We provided summary statistics of target sequences of SARS-CoV-2 in Vietnam and other countries for data scientists to use in downstream analysis for therapeutic targets. For host cells, we proposed a predictive model of the severity of COVID-19 based on public datasets of hospitalization status in Vietnam, incorporating a polygenic risk score. This score uses immunogenic SNP biomarkers as indicators of COVID-19 severity. RESULT: We identified that the Delta variant of SARS-CoV-2 is most prevalent in southern areas of Vietnam and it is different from other areas in the world using various data sources. Our predictive models of COVID-19 severity had high accuracy (Random Forest AUC = 0.81, Elastic Net AUC = 0.7, and SVM AUC = 0.69) and showed that the use of polygenic risk scores increased the models' predictive capabilities. CONCLUSION: We provided a comprehensive analysis for COVID-19 severity in Vietnam. This investigation is not only helpful for COVID-19 treatment in therapeutic target studies, but also could influence further research on the disease progression and personalized clinical outcomes.


Assuntos
COVID-19 , Infecções por Coronavirus , Pneumonia Viral , Betacoronavirus , COVID-19/tratamento farmacológico , COVID-19/epidemiologia , Estudo de Associação Genômica Ampla , Humanos , SARS-CoV-2/genética , Vietnã/epidemiologia
3.
Washington, D.C.; PAHO; 2022-06-09.
em Inglês, Espanhol | PAHO-IRIS | ID: phr-56081

RESUMO

[WEEKLY SUMMARY]. North America: Influenza and SARS-CoV-2 activity remained at low levels. In Canada, influenza activity with influenza A(H3N2) viruses predominating declined slightly and continued above the average of previous seasons for this time of year. In Mexico, influenza positivity with influenza A(H3N2) viruses predominating increased somewhat. In the United States, influenza activity decreased overall, with influenza A(H3N2) viruses predominating and SARS-CoV-2 deaths above expected levels. Caribbean: Influenza activity remained at low levels with predominating influenza A(H3N2). SARS-CoV-2 activity increased slightly in Haiti and Saint Lucia. Central America: Influenza and SARS-CoV-2 activity remained low. In Guatemala, influenza positivity with influenza A(H3N2) viruses predominating increased slightly. In Costa Rica and Nicaragua, SARS-CoV-2 activity and percent positivity increased compared to the previous week. Andean: Influenza activity remained low with A(H3N2) predominance, and SARS-CoV-2 activity declined in most countries. However, RSV activity continued to increase in Bolivia, Colombia, and Ecuador, and influenza activity increased in Peru. Brazil and Southern Cone: Influenza with the predominance of A(H3N2) remained low but continued to increase, and SARS-CoV-2 activity decreased. In Chile and Uruguay, influenza activity continues to increase, and in Paraguay, SARI activity was at moderate levels associated with the co-circulation of influenza SARS-CoV-2 and RSV.


[RESUMEN SEMANAL]. América del Norte: la actividad de influenza y SARS-CoV-2 se mantuvo en niveles bajos. En Canadá, la actividad de influenza disminuyó levemente con predominio de los virus influenza A(H3N2) y continuó por encima del promedio de temporadas anteriores para esta época del año. En México, la positividad de influenza con predominio de influenza A(H3N2) aumentó un poco. En los Estados Unidos, la actividad de la influenza disminuyó en general, con el predominio de los virus de la influenza A(H3N2) y con muertes por SARS-CoV-2 por encima de los niveles esperados. Caribe: la actividad de la influenza permaneció en niveles bajos, con el predominio de la influenza A(H3N2). La actividad del SARS-CoV-2 aumentó levemente en Haití y Santa Lucía. América Central: actividad de la influenza y del SARS-CoV-2 se mantuvo baja. En Guatemala, la positividad de la influenza con predominio de influenza A(H3N2) aumentó levemente. En Costa Rica y Nicaragua, la actividad del SARS-CoV-2 y el porcentaje de positividad aumentaron en comparación con la semana anterior. Andina: la actividad de la influenza se mantuvo baja con predominio de A(H3N2), y la actividad del SARS-CoV-2 disminuyó en la mayoría de los países. Sin embargo, la actividad del VRS continuó aumentando en Bolivia, Colombia y Ecuador; la actividad de la influenza aumentó en Perú. Brasil y Cono Sur: la influenza con predominio de A(H3N2) se mantuvo baja, pero siguió en aumento y la actividad del SARS-CoV-2 disminuyó. En Chile y Uruguay, la actividad de la influenza continúa aumentando, y en Paraguay, la actividad de la IRAG estuvo en niveles moderados asociados con la circulación concurrente de influenza, SARS-CoV-2 y VRS.


Assuntos
Influenza Humana , COVID-19 , SARS-CoV-2 , Betacoronavirus , Regulamento Sanitário Internacional , América , Região do Caribe , Influenza Humana , Regulamento Sanitário Internacional , América , Região do Caribe
4.
Washington, D.C.; PAHO; 2022-06-02.
em Inglês, Espanhol | PAHO-IRIS | ID: phr-56072

RESUMO

[WEEKLY SUMMARY]. North America: Overall, influenza and SARS-CoV-2 activity remained at low levels. In Canada, influenza activity increased above the average of previous seasons for this period at the epidemic threshold, and SARS-CoV-2 activity remained at low levels. In Mexico, SARS-CoV-2 activity decreased. In the United States, influenza activity decreased overall except in some states with influenza A(H3N2) viruses predominating and SARS-CoV-2 activity continued to increase. Caribbean: Influenza activity remained at low levels with predominating influenza A(H3N2), and overall, SARS-CoV-2 activity increased. Central America: Overall, influenza activity remained low, and SARS-CoV-2 activity slightly increased in the subregion. In Costa Rica and Panama, SARS-CoV-2 activity and percent positivity increased compared to previous seasons for the same period. Andean: Overall, influenza activity remained low with A(H3N2) predominance. SARS-CoV-2 activity continued to decline in most countries. Brazil and Southern Cone: Overall, influenza with the predominance of A(H3N2) and SARS-CoV-2 activity decreased. In Chile, ILI activity continued to increase and was associated with increased activity of influenza and RSV. Global: Influenza activity continued to decrease, following a peak in March 2022. In the temperate zones of the northern hemisphere, influenza activity decreased or remained stable. Detections were mainly influenza A(H3N2) viruses and B/Victoria lineage viruses, with some detections of (H1N1)pdm09 viruses. In Central Asia, no influenza detections were reported. Overall, in Europe, influenza continues to decline, with influenza A(H3N2) predominant. In East Asia, detections of influenza B (Victoria lineage) viruses continued to decrease in China. In contrast, influenza A(H3N2) detections increased in the Southern Provinces to make influenza A (H3N2) the predominantly detected virus in China. Elsewhere, influenza illness indicators and activity remained low. In Northern Africa, Tunisia reported a single influenza A (H3N2) detection. In Western Asia, influenza activity was low across reporting countries except for Georgia and Qatar, with elevated detections of mainly influenza A(H3N2), some influenza A(H1N1)pdm09, and B viruses reported, respectively. In tropical Africa, influenza activity remained low, with influenza A(H3N2) predominating, followed by influenza B/Victoria lineage viruses. In Southern Asia, influenza virus detections were at low levels with a few influenza A(H3N2), A(H1N1)pdm09 viruses, and influenza B detections. In South-East Asia, sporadic detections of influenza A(H3N2) were reported in Singapore, and sporadic influenza A and B detections were reported in Malaysia. Influenza detections increased in South Africa and Australia. Overall, COVID-19 positivity from sentinel surveillance increased during the reporting period to 13.0%. The highest increases were observed in the African Region, where positivity was around 20.0%. Activity from non-sentinel sites was varied. Positivity was below 10% overall and in all reporting regions except the Western Pacific Region, where positivity was above 30%. In the South-East Asia Region, positivity decreased but remained high at 24.8%. Positivity increased in the African Region and Eastern Mediterranean Region.


[RESUMEN SEMANAL]. América del Norte: en general, la actividad de influenza y SARS-CoV-2 se mantuvo en niveles bajos. En Canadá, la actividad de la influenza aumentó por encima del promedio de temporadas anteriores para este período en el umbral epidémico, y la actividad de SARS-CoV-2 se mantuvo en niveles bajos. En México disminuyó la actividad del SARS-CoV-2. En los Estados Unidos, la actividad de la influenza disminuyó en general, excepto en algunos estados donde predominaron los virus de la influenza A(H3N2) y la actividad del SARS-CoV-2 siguió en aumento. Caribe: la actividad de la influenza se mantuvo en niveles bajos, predominando la influenza A(H3N2); en general, la actividad del SARS-CoV-2 aumentó. América Central: en general, la actividad de la influenza se mantuvo baja y la actividad del SARS-CoV-2 aumentó levemente en la subregión. En Costa Rica y Panamá, la actividad del SARS-CoV-2 y el porcentaje de positividad aumentaron en comparación con temporadas anteriores para el mismo período. Andina: en general, la actividad de influenza se mantuvo baja con predominio de A(H3N2). La actividad del SARS-CoV-2 continuó disminuyendo en la mayoría de los países. Brasil y Cono Sur: en general, disminuyó la actividad de influenza con predominio de A(H3N2) y SARS-CoV-2. En Chile, la actividad de la ETI continúa aumentando y se asoció con una mayor actividad de influenza y de VRS. Global: la actividad de la influenza siguió disminuyendo, luego de un pico en marzo de 2022. En las zonas templadas del hemisferio norte, la actividad de la influenza disminuyó o se mantuvo estable. Las detecciones fueron principalmente virus A(H3N2) e influenza B linaje Victoria, con algunas detecciones de (H1N1)pdm09. En Asia Central, no se informaron detecciones de influenza. En general, en Europa, la influenza sigue en disminución con predominio de influenza A(H3N2). En el este de Asia, las detecciones de influenza B (linaje Victoria) continuaron en disminución en China. Por el contrario, las detecciones de influenza A(H3N2) aumentaron en las provincias del sur consecuentemente con predominio de influenza A(H3N2) en China. En otros lugares, los indicadores y la actividad de la enfermedad por influenza permanecieron bajos. En el norte de África, Túnez notificó una sola detección de influenza A(H3N2). En Asia occidental, la actividad de influenza fue baja en todos los países que informaron, excepto Georgia y Qatar, con detecciones elevadas principalmente de influenza A(H3N2), algunos virus de influenza A(H1N1)pdm09 e influenza B, respectivamente. En África tropical, la actividad de la influenza se mantuvo baja, predominando influenza A(H3N2), seguida por influenza B linaje Victoria. En el sur de Asia, las detecciones de influenza estuvieron en niveles bajos con algunas detecciones de los virus influenza A(H3N2), A(H1N1)pdm09 e influenza B. En el Sudeste Asiático, se informaron detecciones esporádicas de influenza A(H3N2) en Singapur, y detecciones esporádicas de influenza A y B en Malasia. Las detecciones de influenza aumentaron en Sudáfrica y Australia. En general, durante este periodo del informe, la positividad de la COVID-19 en la vigilancia centinela incrementó alcanzando un 13%. Los mayores aumentos se observaron en la Región de África, donde la positividad estuvo en torno al 20 %. La actividad de los sitios no centinela fue variada. En general, la positividad estuvo por debajo del 10% en todas las regiones informantes excepto en la Región del Pacífico Occidental, donde la positividad estuvo por encima del 30%. En la Región de Asia Sudoriental, la positividad disminuyó pero se mantuvo alta en un 24,8 %. La positividad aumentó en la Región de África y la Región del Mediterráneo Oriental.


Assuntos
Influenza Humana , COVID-19 , SARS-CoV-2 , Betacoronavirus , Regulamento Sanitário Internacional , América , Região do Caribe , Influenza Humana , Regulamento Sanitário Internacional , América , Região do Caribe
5.
Geneva; World Health Organization; 2022-05-25.
em Inglês | WHO IRIS | ID: who-354573
6.
Geneva; World Health Organization; 2022-05-18.
em Inglês | WHO IRIS | ID: who-354476
7.
Geneva; World Health Organization; 2022-05-11.
em Inglês | WHO IRIS | ID: who-354259
8.
Geneva; World Health Organization; 2022-05-04.
em Inglês | WHO IRIS | ID: who-353976
9.
Washington, D.C.; PAHO; 2022-05-24.
em Inglês | PAHO-IRIS | ID: phr-56074

RESUMO

Since the onset of the pandemic in 2020 and up to May 24, 2022, a cumulative total of approximately 523.7 million COVID-19 cases including about 6.3 deaths were reported from all six WHO regions. During the epidemiological week (EW) 20, cases increased in the regions of the Western Pacific (5.6%) and the Americas (6.9%) while they decreased in the four WHO regions. COVID-19 deaths increased in the regions of Europe (30.1%) and the Western Pacific (0.6%) while they decreased in the remaining four WHO regions. Globally, approximately 3,743,444 new COVID-19 cases were reported in EW 20 (May 15, 2022- May 21, 2022) - a 2.6% decrease compared to EW 19 (May 08, 2022-May 14, 2022) (Figure 1). For the same period, 9,814 new COVID-19 deaths were reported globally – a 7.5% relative decrease compared to the previous week. In the region of the Americas, 980,618 cases and 3,622 deaths were reported in EW 20 - a 6.9% increase in cases and 1.1% decrease in deaths compared to the previous week. At the subregional level, COVID-19 cases increased in all four subregions (range: 0.1-12.3% increase). During EW 20, COVID-19 deaths increased in Central America (19.2%) and the Caribbean and Atlantic Ocean Islands (6%), while they observed no significant changes in the two remaining subregions – North America (-2.9%) and South America (-0.5%) – compared to the previous week. The overall weekly case notification rate for the region of the Americas was 95.9 cases per 100,000 population during EW 20 (89.7 the previous week). Between EW 20 and 19, the 14-day COVID-19 death rate was 7.1 deaths per 1 million population (7.8 the previous two weeks). Among 32 countries/territories in the region with available data, COVID-19 hospitalizations increased in 13 countries and territories (range: 1% - 250%) during EW 20 compared to the previous week. Among 28 countries/territories with data available for COVID-19 ICU admissions, 8 observed an increase in weekly ICU admissions (range: 11.1% - 300%).


Assuntos
COVID-19 , Coronavirus , Infecções por Coronavirus , Betacoronavirus , Vacinas , Cobertura Vacinal , Imunização , Genômica , Emergências , América , Região do Caribe
10.
Washington, D.C.; PAHO; 2022-05-25.
em Inglês, Espanhol | PAHO-IRIS | ID: phr-56040

RESUMO

[WEEKLY SUMMARY]. North America: Overall, influenza and SARS-CoV-2 activity remained at low levels. In Canada, influenza activity increased above the average of previous seasons for this period at low intensity levels, and SARS-CoV-2 activity remained at low levels. In Mexico, influenza activity increased above the epidemic threshold to moderate intensity levels and ILI activity at average epidemic levels of previous seasons; SARS-CoV-2 activity decreased. In the United States, influenza activity decreased overall except in some states with influenza A(H3N2) viruses predominating. Caribbean: Influenza activity remained at low levels with predominating influenza A(H3N2), and overall, SARS-CoV-2 activity increased with low number of cases in the subregion. In Saint Lucia, SARS-CoV-2 activity and percent positivity increased. Central America: Overall, influenza activity remained low, and SARS-CoV-2 activity slightly increased in the subregion. In El Salvador, influenza activity remained above average levels at low-intensity levels with A(H3N2) predominance. In Costa Rica and Panama, SARS-CoV-2 activity and percent positivity increased compared to previous seasons for the same period. Andean: Overall, influenza activity remained low with A(H3N2) predominance. SARS-CoV-2 activity continued to decline in most countries, except in Peru, where the influenza activity with the predominance of A(H3N2) continued elevated above the average seasonal levels. In Ecuador, RSV activity continued elevated with increasing SARI and pneumonia activity below the average levels Brazil and Southern Cone: Overall, influenza with the predominance of A(H3N2) and SARS-CoV-2 activity decreased. In Brazil and Argentina, SARS-CoV-2 activity increased slightly compared to the previous week. In Argentina, Chile and Uruguay, influenza A(H3N2) activity continued elevated, while RSV activity continued elevated in Chile and Brazil.


[RESUMEN SEMANAL]. América del Norte: en general, la actividad de la influenza y de SARS-CoV-2 se mantuvo en niveles bajos. En Canadá, la actividad de la influenza aumentó por encima del promedio de temporadas anteriores para esta época del año en nivel de intensidad bajo y la actividad de SARS-CoV-2 se mantuvo en niveles bajos. En México, la actividad de la influenza aumentó por encima del umbral epidémico a niveles de intensidad moderados y la actividad de ETI en niveles epidémicos promedio de las temporadas anteriores; la actividad del SARS-CoV-2 disminuyó. En los Estados Unidos, la actividad de la influenza disminuyó en general excepto en algunos estados con predominio de los virus influenza A(H3N2). Caribe: la actividad de la influenza se mantuvo en niveles bajos, con predominio de influenza A(H3N2) y, en general, la actividad del SARS-CoV-2 aumentó con bajo número de casos en la subregión. En Santa Lucia, aumentó la actividad y el porcentaje de positividad de influenza y SARS-CoV-2. América Central: en general, la actividad de la influenza se mantuvo baja y la actividad del SARS-CoV-2 aumentó en la subregión. En El Salvador, la actividad de influenza se mantuvo por encima del promedio en niveles de baja intensidad con predominio de A(H3N2). En Costa Rica y Panamá, la actividad del SARS-CoV-2 y el porcentaje de positividad aumentaron en comparación con temporadas anteriores para el mismo periodo. Andina: en general, la actividad de influenza se mantuvo baja con predominio de A(H3N2). La actividad de SARS-CoV-2 continuó disminuyendo en la mayoría de los países, excepto en Perú, donde la actividad de influenza con predominio de A(H3N2) continuó elevada por encima de los niveles promedio estacionales. En Ecuador, la actividad del VRS continuó elevada con aumento de la actividad de IRAG y neumonías por debajo de los niveles epidémicos promedio. Brasil y Cono Sur: en general, disminuyó la actividad de influenza con predominio de A(H3N2) y SARS-CoV-2. En Brasil y Argentina, la actividad del SARS-CoV-2 aumentó levemente con respecto a la semana anterior. En Argentina, Chile y Uruguay, la actividad de influenza A(H3N2) continuó elevada, en tanto la actividad del VRS permaneció elevada en Chile y en Brasil.


Assuntos
Influenza Humana , COVID-19 , SARS-CoV-2 , Betacoronavirus , Regulamento Sanitário Internacional , América , Região do Caribe , Influenza Humana , Regulamento Sanitário Internacional , América , Região do Caribe
11.
Washington, D.C.; PAHO; 2022-05-17.
em Inglês | PAHO-IRIS | ID: phr-56035

RESUMO

[Executive Summary]. Since the onset of the pandemic in 2020 and up to May 17, 2022, a cumulative total of approximately 519.2 million COVID-19 cases including nearly 6.3 million deaths were reported from all six WHO regions. During EW 19, COVID-19 weekly cases increased in the regions of Western Pacific (14.1%), Eastern Mediterranean (62.8%), the Americas (27.2%), and Africa (5.9%), while they decreased in Europe and South-East Asia. COVID-19 deaths increased in Africa by 48.3% while they decreased in the remaining five WHO regions (range: -28.5 - -9.9%). Globally, 3,705,498 COVID-19 cases were reported in epidemiological week (EW) 19 (May 08, 2022-May 14, 2022) – a 1% increase compared to EW 18 (May 01, 2022-May 07, 2022) (Figure 1). For the same period, 9,808 COVID-19 deaths were reported globally – a 20.6% relative decrease compared the previous week. In the region of the Americas, 918,425 cases including 3,585 deaths were reported in EW 19 – a 27.2% increase in cases and 16.2% decrease in deaths compared to the previous week. At the subregional level, COVID-19 cases increased in all four subregions (range: 9.3 – 80%). During EW 19, the trends for weekly deaths increased in Central America (2.1%) and the Caribbean and Atlantic Ocean Islands (49.4%) while it declined in North America (-5%) and South America (-22.3%). The overall weekly case notification rate for the region of the Americas was 89.8 cases per 100,000 population during EW 19 (70.6 the previous week). Between EW 19 and 18, the 14-day COVID-19 death rate was 7.7 deaths per 1 million population (8.3 the previous two weeks). Among 33 countries/territories in the region with available data, COVID-19 hospitalizations increased in 18 countries and territories (range: 0.3% - 400%) during EW 19 compared to the previous week. Among 27 countries and territories with available data, COVID-19 Intensive Care Unit (ICU) admissions increased in 13 countries and territories (range: 6.7% - 300%).


Assuntos
COVID-19 , Coronavirus , Infecções por Coronavirus , Betacoronavirus , Vacinas , Cobertura Vacinal , Imunização , Genômica , Emergências , América , Região do Caribe
12.
Washington, D.C.; PAHO; 2022-05-10.
em Inglês | PAHO-IRIS | ID: phr-56034

RESUMO

[Executive Summary]. Since the onset of the pandemic in 2020 and up to May 09, 2022, a cumulative total of about 515 million COVID-19 cases including 6.2 deaths were reported from all six WHO regions. While the global number of new cases and deaths has continued to decline, weekly cases increased in the African Region (12.9%), the region of the Americas (15.3%), and the Western Pacific region (1.1%) during epidemiological week (EW) 18. Similarly, COVID-19 weekly deaths increased in the African Region and the region of the Americas by 87.8% and 3.4%, respectively. Globally, approximately 3,639,510 new COVID-19 cases were reported in epidemiological week (EW) 18 (May 01, 2022-May 07, 2022) – 9.3% decrease compared to EW 17 (April 24, 2022-April 30, 2022) (Figure 1). For the same period, 12,239 new COVID-19 deaths were reported globally – a 24.5% relative decrease compared the previous week. In the region of the Americas, 719,811 cases and 4,385 deaths were reported in EW 18 - a 15.3% and a 3.4% increase, respectively, compared to the previous week. At the subregional level, COVID-19 cases increased in all four subregions (range: 12.7 – 26.2%) during EW 18. In the same period, while South America reported a decline in weekly deaths, the remaining three subregions reported an increase in deaths (range: 4.1 – 49%). The overall weekly case notification rate for the region of the Americas was 69.5 cases per 100,000 population during EW 18 (61 the previous week). Between EW 18 and 17, the 14-day COVID-19 death rate was 8.4 deaths per 1 million population (8.3 the previous two weeks). Among 32 countries/territories in the region with available data, COVID-19 hospitalizations increased in 10 countries and territories (range: 4.9% - 100%) during EW 18 compared to the previous week. Among 25 countries/territories with available data, COVID-19 ICU admissions increased in 5 countries and territories (range: 7.9% - 100%).


Assuntos
COVID-19 , Coronavirus , Infecções por Coronavirus , Betacoronavirus , Vacinas , Cobertura Vacinal , Imunização , Genômica , Emergências , América , Região do Caribe
13.
Washington, D.C.; PAHO; 2022-05-03.
em Inglês | PAHO-IRIS | ID: phr-56033

RESUMO

[Executive Summary]. Since the onset of the pandemic in 2020 and up to May 03, 2022, a cumulative total of over 511 million COVID-19 cases including about 6.2 million deaths were reported from all six WHO regions. During epidemiological week (EW) 17, cases declined in all WHO regions except for the Region of the Americas . Similarly, weekly deaths declined in all but one WHO region – the South-East Asia Region – where a 68.9% increase was observed compared to EW 16 – most likely due to reporting delays like in the previous week. Globally, approximately 3.8 million new COVID-19 cases were reported in EW 17 (April 24, 2022-April 30, 2022) - a 17.4% decrease compared to EW 16 (April 17, 2022-April 23, 2022) (Figure 1). For the same period, 15,522 new COVID-19 deaths were reported globally – a 4.1% relative decrease compared the previous week. In the region of the Americas, 616,348 cases and 4,200 deaths were reported in EW 17 - a 12.7% increase in cases and 0.2% decrease in deaths compared to the previous week. At the subregional level, while South America reported a decline in COVID-19 cases during EW17 (8% decrease), the remaining three subregions reported an increase (range: 15.4% - 53.4% increase)). In the same period, two subregions reported an increase in deaths – South America (8.7% increase) and Caribbean and Atlantic Ocean Islands (39.6% increase). The overall weekly case notification rate for the region of the Americas continued to increase with 60.3 cases per 100,000 population during EW 17 (53.5 the previous week). The 14-day COVID-19 death rate declined with 8.2 deaths per 1 million population reported during EW 16 and 17 (9 the previous two weeks). Among 32 countries/territories in the region with available data, COVID-19 hospitalizations increased in 11 countries/territories (range: 1.6% - 166.7%) during EW 17 relative to the previous week. Among 26 countries/territories with available data, COVID-19 ICU admissions increased in 11 countries and territories (range: 0.6 – 100%).


Assuntos
COVID-19 , Coronavirus , Infecções por Coronavirus , Betacoronavirus , Vacinas , Cobertura Vacinal , Imunização , Genômica , Emergências , América
14.
Washington, D.C.; PAHO; 2022-05-06.
em Inglês | PAHO-IRIS | ID: phr-56025

RESUMO

Following an outbreak of a novel Coronavirus (COVID-19) in Wuhan City, Hubei Province of China, rapid community, regional and international spread occurred with exponential growth in cases and deaths. On 30 January 2020, the Director-General (DG) of the WHO declared the COVID-19 outbreak a public health emergency of international concern (PHEIC) under the International Health Regulations (IHR) (2005). The first case in the Americas was confirmed in the USA on 20 January 2020, followed by Brazil on 26 February 2020. Since then, COVID-19 has spread to all 56 countries and territories in the Americas. SITUATION IN NUMBERS IN THE AMERICAS as of 6 May 2022: 56 Countries, territories, and areas affected; 153,793,149 Confirmed cases; 2,731,4555 Deaths; 1,791,144,461 Vaccine doses administered.


Assuntos
COVID-19 , Coronavirus , Infecções por Coronavirus , Betacoronavirus , Análise de Situação , Emergências , América , Região do Caribe
15.
Washington, D.C.; PAHO; 2022-05-19.
em Inglês, Espanhol | PAHO-IRIS | ID: phr-56011

RESUMO

[WEEKLY SUMMARY]. North America: Overall, influenza and SARS-CoV-2 activity remained at low levels. In Canada, influenza activity increased above the average of previous seasons for this period at low intensity levels, and SARS-CoV-2 activity decreased and remained at low levels. In Mexico, influenza activity increased above the epidemic threshold and was at the average of previous seasons, and SARS-CoV-2 activity decreased. In the United States, influenza activity varied within regions and continued to increase in some states with influenza A(H3N2) viruses predominating. Caribbean: Influenza activity remained at low levels, with predominating influenza A(H3N2), and overall, SARS-CoV-2 activity declined in most countries. In Belize and Dominica, influenza and SARS-CoV-2 activity and percent positivity increased. Central America: Overall, influenza activity remained low and SARS-CoV-2 activity decreased in most countries. In El Salvador, influenza activity remained above-average levels at low-intensity levels. In Costa Rica and Panama, SARS-CoV-2 activity and percent positivity increased compared to previous seasons. Andean: Overall, influenza activity remained low with A(H3N2) predominance. SARS-CoV-2 activity continued to decline in most countries, except in Peru, where the influenza activity with the predominance of A(H3N2) continued elevated above the average seasonal levels. In Ecuador, RSV activity continued elevated. Brazil and Southern Cone: Overall, influenza with the predominance of A(H3N2) and SARS-CoV-2 activity decreased. In Brazil, SARS-CoV-2 activity increased slightly compared to the previous week. In Chile and Uruguay, influenza A(H3N2) activity and SARS-CoV-2 positivity increased slightly at low intensity levels. RSV activity continued elevated in Chile and Uruguay. Global: Influenza activity continued to decrease, following a peak in March 2022. In the temperate zones of the northern hemisphere, influenza activity decreased or remained stable. Detections were mainly influenza A(H3N2) viruses and B/Victoria lineage viruses, with some detections of A(H1N1)pdm09 viruses. In Central Asia, a single influenza B detection was reported in Kazakhstan. In East Asia, influenza activity with mainly influenza B/Victoria lineage. Overall, in Europe, influenza continues to decline, with influenza A(H3N2) predominant. Very little RSV activity was observed. Detections continued to decrease in China while A(H3N2) became the predominantly detected virus across the southern provinces in China. Elsewhere, influenza illness indicators and activity remained low. In Northern Africa, Tunisia continued to report few detections of mainly influenza A(H3N2) and one influenza A(H1N1)pdm09 detection, while Egypt reported increasing detections of influenza B followed by A(H3N2). In Western Asia, influenza activity was low across reporting countries, except Georgia, where detections of influenza A(H3N2) continued to be reported although decreasing. In Southern Asia, influenza virus detections were at low levels, with a few detections of A(H3N2) and A(H1N1)pdm09 viruses. In South-East Asia, low A(H3N2) detections were reported in Singapore and Timor-Leste. In the temperate zones of the southern hemisphere, influenza activity was low overall, as expected at this time of year. Overall, COVID positivity from sentinel surveillance increased and was just above 10% during the reporting period. Activity from non-sentinel sites was varied.


[RESUMEN SEMANAL]. América del Norte: en general, la actividad de la influenza y de SARS-CoV-2 se mantuvo en niveles bajos. En Canadá, la actividad de la influenza aumentó por encima del promedio de temporadas anteriores para esta época del año en nivel de intensidad bajo y la actividad de SARS-CoV-2 disminuyó y se mantuvo en niveles bajos. En México, la actividad de la influenza aumentó por encima del umbral epidémico y estuvo en el promedio de las temporadas anteriores y la actividad y el porcentaje de positividad del SARS-CoV-2 aumentó. En los Estados Unidos, la actividad de la influenza varía según la región y siguió aumentando en algunas zonas del país con predominio de los virus influenza A(H3N2). Caribe: la actividad de la influenza se mantuvo en niveles bajos, con predominio de influenza A(H3N2) y, en general, la actividad del SARS-CoV-2 disminuyó en la mayoría de los países. En Belice y Dominica, aumentó la actividad y el porcentaje de positividad de influenza y SARS-CoV-2. América Central: en general, la actividad de la influenza se mantuvo baja y la actividad del SARS-CoV-2 disminuyó en la mayoría de los países. En El Salvador, la actividad de influenza se mantuvo por encima del promedio en niveles de baja intensidad. En Costa Rica y Panamá, la actividad del SARS-CoV-2 y el porcentaje de positividad aumentaron en comparación con temporadas anteriores. Andina: en general, la actividad de influenza se mantuvo baja con predominio de A(H3N2). La actividad de SARS-CoV-2 continuó disminuyendo en la mayoría de los países, excepto en Perú, donde la actividad de influenza con predominio de A(H3N2) continuó elevada por encima de los niveles promedio estacionales. En Ecuador, la actividad del VRS continuó elevada. Brasil y Cono Sur: en general, disminuyó la actividad de influenza con predominio de A(H3N2) y SARS-CoV-2. En Brasil, la actividad del SARS-CoV-2 aumentó levemente con respecto a la semana anterior. En Chile y Uruguay, la actividad de influenza A(H3N2) y la positividad de SARS-CoV-2 aumentaron levemente en niveles de baja intensidad. La actividad del VRS continuó elevada en Chile y Uruguay. Global: la actividad de la influenza siguió disminuyendo, luego de un pico en marzo de 2022. En las zonas templadas del hemisferio norte, la actividad de la influenza disminuyó o se mantuvo estable. Las detecciones fueron principalmente virus de la influenza A(H3N2) e influenza B linaje Victoria, con algunas detecciones de los virus A(H1N1)pdm09. En Asia Central, se notificó una sola detección de influenza B en Kazajstán. En el este de Asia, la actividad de la influenza fue principalmente de influenza B linaje Victoria. En general, en Europa, la influenza sigue disminuyendo con predominio de influenza A(H3N2). Se observó muy poca actividad de VRS. Las detecciones continuaron disminuyendo en China, mientras que el A(H3N2) se convirtió en el virus predominantemente detectado en las provincias del sur de China. En otros lugares, los indicadores y la actividad de la enfermedad por influenza permanecieron bajos. En el norte de África, Túnez continuó informando pocas detecciones principalmente de influenza A(H3N2) y una detección de influenza A(H1N1)pdm09, mientras que Egipto reportó un aumento en las detecciones de influenza B seguida de A(H3N2). En Asia occidental, la actividad de la influenza fue baja en todos los países que notificaron, excepto en Georgia, donde continuaron las notificaciones de detecciones de influenza A(H3N2), aunque en disminución. En el sur de Asia, las detecciones del virus de la influenza estuvieron en niveles bajos, con algunas detecciones de los virus A(H3N2) y A(H1N1)pdm09. En el Sudeste Asiático, se informaron detecciones bajas de A(H3N2) en Singapur y Timor-Leste. En las zonas templadas del hemisferio sur, en general, la actividad de la influenza fue baja como se esperaba en esta época del año. En general, la positividad de la COVID de la vigilancia centinela aumentó y estuvo justo por encima del 10 % durante el período del informe. La actividad de los sitios no centinela fue variada.


Assuntos
COVID-19 , Influenza Humana , SARS-CoV-2 , Betacoronavirus , Regulamento Sanitário Internacional , América , Região do Caribe , Influenza Humana , Regulamento Sanitário Internacional , América , Região do Caribe
16.
Washington, D.C.; OPS; 2022-05-17. (OPS/IMS/EIH/COVID-19/22-0016).
Não convencional em Espanhol | PAHO-IRIS | ID: phr-56002

RESUMO

Desde el inicio de la pandemia de COVID-19, se han desarrollado un gran número de ensayos clínicos para evaluar la eficacia y la seguridad de diversas intervenciones para reducir las hospitalizaciones y evitar la progresión a un cuadro grave en las personas con infección por el SARS-CoV-2. Actualmente, la OMS y la OPS recomiendan el uso de corticoesteroides, tocilizumab, baricitinib y casirivimab e imdevimab (este último, en pacientes seronegativos para la COVID-19) y proponen el uso del sotrovimab, el casirivimab, el imdevimab y el molnupiravir en pacientes con enfermedad leve que presentan riesgo alto de complicaciones. Otras intervenciones terapéuticas posibles se encuentran en fase de investigación o de evaluación. Con el fin de apoyar la toma de decisiones para el manejo de los pacientes, la OPS presenta esta edición actualizada de las consideraciones para el uso racional de los antivirales, los anticuerpos monoclonales y otras intervenciones, en las que se tiene en cuenta la evidencia más actualizada, el estado de la vacunación, el acceso y los costos para los países de la Región de las Américas.


Assuntos
COVID-19 , Betacoronavirus , SARS-CoV-2
17.
Washington, D.C.; PAHO; 2022-05-11.
em Inglês, Espanhol | PAHO-IRIS | ID: phr-55976

RESUMO

[WEEKLY SUMMARY]. North America: Overall, influenza and SARS-CoV-2 activity remained at low levels. In Canada, influenza activity increased above the average of previous seasons for this period at low intensity levels, and SARS-CoV-2 activity decreased and remained at low levels. In Mexico, influenza activity remained stable below the average of previous seasons, and SARS-CoV-2 activity decreased. In the United States, influenza activity varied within regions and continued to increase in some states with influenza A(H3N2) viruses predominating. Caribbean: Influenza activity remained at low levels, with predominating influenza A(H3N2), and overall, SARS-CoV-2 activity continued to decline. In Belize, influenza activity and percent positivity increased. In Jamaica and Saint Lucia, SARS-CoV-2 percent positivity increased at low levels compared to the previous seasons. In Puerto Rico, the percentage of visits for influenza-like illness continued to increase to high levels for this time of year. Central America: Overall, influenza activity remained low and SARS-CoV-2 activity decreased in most countries. In El Salvador, influenza activity remained above-average levels at low-intensity levels. In Panama, SARS-CoV-2 activity and percent positivity increased compared to previous seasons. Andean: Overall, influenza activity remained low with A(H3N2) predominance. SARS-CoV-2 activity continued to decline in most countries. In Ecuador, influenza activity decreased to above-average baseline levels for previous years; and RSV activity was higher than in previous years, except in 2015 and 2016. In Peru, influenza activity increased but remained at low levels compared to previous weeks. Brazil and Southern Cone: Overall, influenza activity decreased with the predominance of A(H3N2). SARS-CoV-2 activity decreased. In Brazil, RSV percent positivity increased to high-intensity levels above the levels observed in 2021, but below the levels of 2016-17 and 2019; and SARS-CoV-2 activity remained above the levels observed in 2021. In Argentina, influenza activity increased at high intensity levels and SARS-CoV-2 activity slightly increased.


[RESUMEN SEMANAL]. América del Norte: en general, la actividad de la influenza y de SARS-CoV-2 se mantienen en niveles bajos. En Canadá, la actividad de la influenza aumentó por encima del promedio de temporadas anteriores para esta época del año en nivel de intensidad bajo y la actividad de SARS-CoV-2 disminuyó y se mantiene en niveles bajos. En México, la actividad de la influenza se mantiene estable por debajo del promedio de temporadas anteriores y la actividad del SARS-CoV-2 disminuyó. En los Estados Unidos, la actividad de la influenza varía según la región y sigue aumentando en algunas zonas del país con predominio de los virus influenza A(H3N2). Caribe: la actividad de la influenza se mantuvo en niveles bajos, con predominio de influenza A(H3N2) y la actividad del SARS-CoV-2 continuó en disminución. En Belice aumentó la actividad y porcentaje de positividad de influenza. En Jamaica y Santa Lucía el porcentaje de positividad del SARS-CoV-2 aumentó en nivel de intensidad bajo con respecto a los registrados previamente. En Puerto Rico, el porcentaje de visitas por enfermedad tipo influenza continúa en aumento a niveles altos para esta época del año. América Central: en general, la actividad de la influenza se mantuvo baja y la actividad del SARS-CoV-2 disminuyó en la mayoría de los países. En El Salvador la actividad de la influenza permaneció por encima de los niveles promedio en niveles de intensidad bajos. En Panamá la actividad y porcentaje de positividad para el SARS-CoV-2 aumentaron en comparación con periodos previos. Andina: en general, la actividad de la influenza continuó baja con predominio de A(H3N2). La actividad del SARS-CoV-2 continuó disminuyendo en la mayoría de los países. En Ecuador, la actividad de la influenza disminuyó a los niveles de referencia por encima del promedio de los años anteriores. La actividad del VRS fue mayor que en años anteriores, excepto en 2015 y 2016. En Perú, la actividad de influenza aumentó en las últimas semanas, pero se mantiene en niveles de baja intensidad Brasil y Cono Sur: en general, la actividad de la influenza con predominio de A(H3N2) y SARS-CoV-2 tienden a la disminución. En Brasil el porcentaje de positividad de virus respiratorio sincitial se mantuvo en niveles altos por encima de los niveles observados a finales de 2021, pero por debajo de los niveles de las temporadas 2016-17 y 2019 y la actividad y porcentaje de positividad de SARS-CoV2 se mantuvo en niveles altos por encima de lo observado a fines de 2021. En Argentina la actividad y porcentaje de positividad para influenza aumentaron a niveles de intensidad alta y la actividad de SARS-CoV-2 aumentó levemente.


Assuntos
COVID-19 , Influenza Humana , SARS-CoV-2 , Betacoronavirus , Regulamento Sanitário Internacional , América , Região do Caribe , Influenza Humana , Regulamento Sanitário Internacional , América , Região do Caribe
18.
Washington, D.C.; PAHO; 2022-05-09. (PAHO/NMH/MH/COVID-19/22-0001).
Não convencional em Inglês | PAHO-IRIS | ID: phr-55972

RESUMO

The COVID-19 HEalth caRe wOrkErs Study (HEROES): Regional Report from the Americas is a multicenter prospective cohort study to assess the impact of the COVID-19 pandemic on the mental health of health care workers in 26 countries on four continents and how it is affected by several factors at different interrelated levels: individual, family, occupational, and social. This brief report presents the evidence generated from the baseline survey of 11 participating countries in the Region of the Americas. Using validated scales, the findings show high rates of depressive symptoms, suicidal ideation, and psychological distress in several countries of the Region. The spirit of the project is not only to generate quality scientific evidence on the mental health of health care workers, but also to help develop interventions (both individual and institutional) and policies to address the negative impacts of the COVID-19 pandemic on mental health.


Assuntos
COVID-19 , Betacoronavirus , Coronavirus , Saúde Mental , Fatores de Risco , Doenças não Transmissíveis , Mão de Obra em Saúde , Vigilância do Ambiente de Trabalho , América
19.
Washington, D.C.; PAHO; 2022-05-05.
em Inglês, Espanhol | PAHO-IRIS | ID: phr-55958

RESUMO

[WEEKLY SUMMARY]. North America: Overall, influenza activity remained at low levels, SARS-CoV-2 activity continued to decline, and percent positivity for SARS-Cov2 remained at low levels. In Canada, influenza activity and SARS-CoV-2 activity remained at low levels. In Mexico, influenza activity has increased but remained below the average of previous seasons, and SARS-CoV-2 activity decreased. In the United States, influenza activity varied within regions and continued to increase in some states with influenza A(H3N2) viruses predominating. SARS-CoV-2 activity continued to decline. Caribbean: Influenza activity remained at low levels, with predominating influenza A(H3N2), and overall, SARS-CoV-2 activity continued to decline. In Dominica, SARI activity increased and remains below baseline levels. In Puerto Rico, the percentage of visits for influenza-like illness continued to increase to high levels for this time of year. Central America: Overall, influenza activity remained low and SARS-CoV-2 activity decreased in most countries. In El Salvador, influenza activity remained above-average levels at low-intensity levels. Andean: Overall, influenza activity remained low with A(H3N2) predominance. SARS-CoV-2 activity continued to decline in most countries. In Ecuador, influenza activity decreased to above-average baseline levels for previous years; and RSV activity was higher than in previous years, except in 2015 and 2016. In Peru, influenza activity increased with A(H3N2) predominance. Brazil and Southern Cone: Overall, influenza activity tends to decrease with the predominance of A(H3N2). SARS-CoV-2 activity decreased, except in Brazil, where SARS-CoV-2 percent positivity increased to high-intensity levels above the levels observed in 2021. Global: Influenza activity remained low, with a further decrease in some areas. In the temperate zones of the northern hemisphere, influenza activity seems to decrease. In Europe, overall influenza activity appeared to decline, with influenza A(H3N2) predominant. In Central Asia, sporadic influenza B detections were reported in Kazakhstan. In East Asia, influenza activity with mainly influenza B/Victoria lineage detections continued to decrease in China. ILI rate and pneumonia hospitalizations remained elevated in Mongolia. Elsewhere, influenza illness indicators and activity remained low. In Northern Africa, decreased detections of influenza A(H3N2) were reported in Tunisia. In Western Asia, Georgia reported increased detections of influenza A(H3N2). In tropical Africa, influenza activity was informed mainly from Eastern Africa, with influenza A(H3N2) predominating, followed by influenza B viruses. In Southern Asia, influenza virus detections were at low levels overall. Only Malaysia reported influenza detections of influenza A(H3N2) and B viruses in South-East Asia. In the temperate zones of the southern hemisphere, influenza activity remained low overall. However, detections of influenza A viruses (with A(H3N2) predominant among the subtyped viruses) continued to be reported in South Africa. SARS-CoV-2 percent positivity from sentinel surveillance decreased below 10% in all WHO regions during this reporting period. Overall positivity from non-sentinel sites also showed a decreasing trend.


[RESUMEN SEMANAL]. América del Norte: en general, la actividad de la influenza se mantuvo en niveles bajos La actividad del SARS-CoV-2 continuó disminuyendo y el porcentaje de positividad de SARS-Cov2 se mantiene en niveles bajos. En Canadá, la actividad de la influenza y la actividad de SARS-CoV-2 se mantiene en niveles bajos En México, la actividad de la influenza ha aumentado pero se mantiene por debajo del promedio de temporadas anteriores y la actividad del SARS-CoV-2 disminuyó. En los Estados Unidos, la actividad de la influenza varía según la región y sigue aumentando en algunas zonas del país con predominio de los virus influenza A(H3N2). La actividad del SARS-CoV-2 siguió en disminución. Caribe: la actividad de la influenza se mantuvo en niveles bajos, con predominio de influenza A(H3N2) y la actividad del SARS-CoV-2 continuó en disminución. En Dominica, la actividad de las IRAG aumentó y se mantiene por debajo de los niveles de referencia. En Puerto Rico, el porcentaje de visitas por enfermedad tipo influenza continúa en aumento a niveles altos para esta época del año. América Central: en general, la actividad de la influenza se mantuvo baja y la actividad del SARS-CoV-2 disminuyó en la mayoría de los países. En El Salvador la actividad de la influenza permaneció por encima de los niveles promedio en niveles de intensidad bajos. Andina: en general, la actividad de la influenza continuó baja con predominio de A(H3N2). La actividad del SARS-CoV-2 continuó disminuyendo en la mayoría de los países. En Ecuador, la actividad de la influenza disminuyó a los niveles de referencia por encima del promedio de los años anteriores. La actividad del VRS fue mayor que en años anteriores, excepto en 2015 y 2016. En Perú, la actividad de influenza aumentó con predominio de A(H3N2). Brasil y Cono Sur: en general, la actividad de la influenza con predominio de A(H3N2) y SARS-CoV-2 tienden a la disminución, excepto en Brasil en donde el porcentaje de positividad de SARS-CoV2 aumentó a niveles altos por encima de los niveles observados a fines de 2021. Global: la actividad de la influenza se mantuvo baja, con una disminución adicional en algunas áreas. En las zonas templadas del hemisferio norte, la actividad de la influenza parece disminuir. En Europa, la actividad general de la influenza pareció disminuir, predominando la influenza A(H3N2). En Asia Central, se informaron detecciones esporádicas de influenza B en Kazajstán. En el este de Asia, la actividad de la influenza principalmente con detecciones de influenza B linaje Victoria continuó disminuyendo en China. La tasa de ETI y las hospitalizaciones por neumonía permanecieron elevadas en Mongolia. En otros lugares, los indicadores y la actividad de la enfermedad por influenza permanecieron bajos. En el norte de África, se informó una disminución de las detecciones de influenza A(H3N2) en Túnez. En Asia Occidental, Georgia informó un aumento en las detecciones de influenza A(H3N2). En África tropical, se notificó la actividad de la influenza principalmente en África oriental, predominando la influenza A(H3N2), seguida por los virus de la influenza B. En el sur de Asia, las detecciones del virus de la influenza estuvieron en niveles bajos en general. Solo Malasia notificó detecciones de virus de la influenza A(H3N2) y B en el sudeste asiático. En las zonas templadas del hemisferio sur, la actividad de la influenza se mantuvo baja en general. Sin embargo, continuó la notificación de detecciones de virus influenza A(H3N2) (predominante entre los virus a los que se les determinó el subtipo) en Sudáfrica. El porcentaje de positividad de SARS-CoV-2 en la vigilancia centinela disminuyó por debajo del 10% en todas las regiones durante este período de informe. La positividad general de los sitios no centinela también mostró una tendencia a la baja.


Assuntos
COVID-19 , Influenza Humana , SARS-CoV-2 , Betacoronavirus , Regulamento Sanitário Internacional , América , Região do Caribe , Influenza Humana , Regulamento Sanitário Internacional , América , Região do Caribe
20.
Enferm. infecc. microbiol. clín. (Ed. impr.) ; 40(5): 1-7, Mayo, 2022. graf, tab
Artigo em Inglês | IBECS | ID: ibc-203498

RESUMO

IntroductionHealthcare workers have a high risk of cross-infection during the care of Covid-19 cases. Personal protective equipment can reduce the risk. However, healthcare workers must be trained for the proper use of personal protective equipment to decrease exposure risk. This study aimed to investigate whether videos available on YouTube, presenting procedures of donning and doffing personal protective equipment, can be a useful learning resource for healthcare workers.MethodsA search of YouTube was conducted using the keywords “Covid-19, personal protective equipment, donning, doffing”. Two investigators reviewed each video and collected the basic video information. Total videos were assessed independently as educationally useful and non-useful categories using a valid tool. The relationship of each video's usefulness with viewers’ preferences and the upload source were analyzed.ResultsA total of 300 videos were assessed; 66 (22%) fulfilled the inclusion criteria. Total video scores of educationally useful videos were higher than non-useful ones; the differences were significant. Healthcare/government agencies and hospitals mostly created educationally useful videos, e-learning platforms, and individuals mainly created non-useful videos. Significant correlations were observed between the video's usefulness and the total view and views per day.ConclusionsDuring a pandemic, YouTube might be a resource for learning donning and doffing of personal protective equipment for healthcare workers if an appropriate selection process applied for determining educationally useful videos.


IntroducciónLos trabajadores de la salud tienen un alto riesgo de infección cruzada durante la atención de los casos de COVID-19. El equipo de protección personal puede reducir el riesgo. Sin embargo, los trabajadores de la salud deben estar capacitados para el uso adecuado del equipo de protección personal para disminuir el riesgo de exposición. Este estudio tuvo como objetivo investigar si los videos disponibles en YouTube, que presentan procedimientos para ponerse y quitarse el equipo de protección personal, pueden ser un recurso de aprendizaje útil para los trabajadores de la salud.MétodosSe realizó una búsqueda en YouTube utilizando las palabras clave «COVID-19, equipo de protección personal, ponerse, quitarse». Dos investigadores revisaron cada video y recopilaron la información básica del mismo. Los videos totales se evaluaron de forma independiente como categorías educativas útiles y no útiles utilizando una herramienta válida. Se analizó la relación de la utilidad de cada video con las preferencias de los espectadores y la fuente de carga.ResultadosSe evaluaron un total de 300 videos; 66 (22%) cumplieron los criterios de inclusión. Los puntajes totales de videos útiles para la educación fueron más altos que los no útiles; las diferencias fueron significativas. Las agencias de salud/gubernamentales y los hospitales en su mayoría crearon videos útiles para la educación, plataformas de aprendizaje electrónico y las personas crearon principalmente videos no útiles. Se observaron correlaciones significativas entre la utilidad del video, la vista total y las vistas por día.ConclusionesDurante una pandemia, YouTube podría ser un recurso para aprender a ponerse y quitarse el equipo de protección personal para los trabajadores de la salud si se aplica un proceso de selección apropiado para determinar videos útiles desde el punto de vista educativo.


Assuntos
Humanos , Masculino , Feminino , Ciências da Saúde , Pessoal de Saúde , Equipamento de Proteção Individual , Pandemias , Betacoronavirus , Riscos Ocupacionais , Educação em Saúde , Doenças Transmissíveis
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...